IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.266
AS - Asia 1.979
EU - Europa 1.446
SA - Sud America 284
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 109
OC - Oceania 6
Totale 7.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.175
CN - Cina 762
SG - Singapore 446
IE - Irlanda 414
HK - Hong Kong 263
VN - Vietnam 254
RU - Federazione Russa 247
BR - Brasile 205
DE - Germania 165
IT - Italia 136
FR - Francia 117
FI - Finlandia 112
IN - India 58
GB - Regno Unito 53
CA - Canada 51
ZA - Sudafrica 45
BD - Bangladesh 34
JP - Giappone 33
SE - Svezia 33
UA - Ucraina 31
AR - Argentina 29
BE - Belgio 29
CZ - Repubblica Ceca 28
MX - Messico 24
EC - Ecuador 20
PL - Polonia 19
ID - Indonesia 18
NG - Nigeria 18
IQ - Iraq 14
PK - Pakistan 13
TR - Turchia 13
ES - Italia 12
CO - Colombia 11
NL - Olanda 9
PH - Filippine 9
SA - Arabia Saudita 9
MA - Marocco 8
AT - Austria 7
EG - Egitto 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
TN - Tunisia 6
UZ - Uzbekistan 6
CM - Camerun 5
IL - Israele 5
JO - Giordania 5
KR - Corea 5
BO - Bolivia 4
ET - Etiopia 4
HR - Croazia 4
JM - Giamaica 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
AU - Australia 3
DZ - Algeria 3
HN - Honduras 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CD - Congo 2
CI - Costa d'Avorio 2
CL - Cile 2
GR - Grecia 2
GT - Guatemala 2
IM - Isola di Man 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MG - Madagascar 1
MM - Myanmar 1
MR - Mauritania 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 7.084
Salva come PNG Salva come JPEG
Città #
Chandler 455
Dublin 413
San Jose 318
Ashburn 284
Hong Kong 254
Beijing 243
Singapore 217
Dallas 172
Council Bluffs 106
Los Angeles 104
Boardman 88
Lauterbourg 82
Helsinki 74
Hanoi 73
Ho Chi Minh City 71
Shanghai 71
Munich 69
Moscow 68
Princeton 65
Lawrence 63
Medford 61
New York 56
Nanjing 51
Jacksonville 49
Wilmington 44
Pavia 41
Ann Arbor 38
Johannesburg 38
Tokyo 33
Buffalo 32
Redondo Beach 32
Brussels 29
Orem 28
Atlanta 26
Milan 26
Santa Clara 26
Hebei 25
Changsha 22
Turku 22
Brno 21
Nanchang 20
São Paulo 20
Brooklyn 19
San Francisco 19
Hangzhou 18
Montreal 18
Warsaw 18
The Dalles 17
Columbus 16
Da Nang 16
Toronto 16
Haiphong 15
Tianjin 15
Chennai 14
Frankfurt am Main 14
Houston 14
Seattle 14
Shenyang 14
London 13
Jiaxing 12
Mexico City 12
Chicago 11
Denver 11
Düsseldorf 10
Monza 10
Lagos 9
Poplar 9
Quito 9
Baghdad 7
Berlin 7
Des Moines 7
Fairfield 7
Falkenstein 7
Falls Church 7
Guayaquil 7
Nuremberg 7
Port Harcourt 7
Thái Nguyên 7
Amsterdam 6
Brasília 6
Cagliari 6
Dhaka 6
Guangzhou 6
Memphis 6
Paris 6
Phoenix 6
Rio de Janeiro 6
Ankara 5
Belo Horizonte 5
Biên Hòa 5
Charlotte 5
Curitiba 5
Hyderabad 5
Hải Dương 5
Kuala Lumpur 5
Lahore 5
Raleigh 5
Redwood City 5
Rome 5
Stockholm 5
Totale 4.582
Salva come PNG Salva come JPEG
Nome #
Rauwolfia vomitoria (Apocynaceae): A comprehensive insight into its botany, ethnomedicinal uses, pharmacology, phytochemistry, and clinical trials 436
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 175
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 168
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 142
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 140
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 138
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 136
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 131
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 129
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 119
Fluorescing fatty acids in rat fatty liver models 118
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 115
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 115
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 115
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 114
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 114
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 111
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 106
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 102
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 101
Fluorescence excitation properties of bilirubin in solution and in serum 101
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 99
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 99
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 98
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 96
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 94
Immobilized amyloid Aβ peptides support platelet adhesion and activation 94
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 94
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 93
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 93
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 89
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 88
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 88
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 88
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 87
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 87
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 86
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 85
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 83
Autofluorescence detection of liver oxidative damage products 82
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 81
SerpinB3 administration protects liver against ischemia-reperfusion injury 80
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 80
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 79
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 79
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 78
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 78
Changes in glutathione content in liver diseases: An update 77
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 77
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 77
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 77
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 74
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 73
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 72
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 70
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 70
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 70
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 70
MPEP administration reduces steatosis and inflammation in ob/ob mice 70
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 69
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 69
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 68
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 65
Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis 64
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 62
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 62
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 61
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 61
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 61
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 59
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 57
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 56
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 56
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 52
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 52
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 48
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 42
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 37
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 30
Molecular Targets in Liver Disease 11
Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats 11
The Proline-Rich Tyrosine Kinase Pyk2 Regulates Platelet Activation and Microvascular Thrombosis in a Model of Low-Grade Endotoxemia 4
Totale 7.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022323 0 3 4 3 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
2024/20251.270 26 86 22 21 20 92 102 38 332 76 157 298
2025/20263.000 203 168 327 313 398 141 552 118 281 241 95 163
2026/2027413 271 142 0 0 0 0 0 0 0 0 0 0
Totale 7.238